A drug which is said to "reboot" the immune system has been shown to be an effective treatment for multiple sclerosis (MS), a study has found.
The results of the trials were so encouraging in reducing the number of attacks in those affected that the MS Society is campaigning for the drug to become available on the NHS.
The research showed that alemtuzumab significantly reduced the number of attacks or relapses by people with MS compared to the current drug interferon beta-1a which is known commercially as Rebif.
More top news
The Food Standards Agency said the product can be returned "from where it was bought for a full refund."
The car giant said it would cut 1,160 jobs at the plant in Bridgend.
Rain and wind clearing tomorrow, leaving a drier and brighter day behind.